IRAK1: a critical signaling mediator of innate immunity.
暂无分享,去创建一个
[1] S. Wasserman,et al. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. , 1999, Journal of immunology.
[2] Liwu Li,et al. Regulation of IL-1 Receptor-Associated Kinases by Lipopolysaccharide1 , 2002, The Journal of Immunology.
[3] T. Parsons,et al. Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop. , 2007, Biochemical and biophysical research communications.
[4] Liwu Li,et al. IRAK1 Serves as a Novel Regulator Essential for Lipopolysaccharide-induced Interleukin-10 Gene Expression*♦ , 2004, Journal of Biological Chemistry.
[5] J. Haas,et al. Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. , 1994, The Journal of biological chemistry.
[6] K. Resch,et al. The death domain of IRAK-1: an oligomerization domain mediating interactions with MyD88, Tollip, IRAK-1, and IRAK-4. , 2007, Biochemical and biophysical research communications.
[7] Yingle Liu,et al. The IRAK-1-BCL10-MALT1-TRAF6-TAK1 Cascade Mediates Signaling to NF-κB from Toll-like Receptor 4* , 2006, Journal of Biological Chemistry.
[8] Crafford A. Harris,et al. Interleukin (IL)-1 Receptor–associated Kinase (IRAK) Requirement for Optimal Induction of Multiple IL-1 Signaling Pathways and IL-6 Production , 1998, The Journal of experimental medicine.
[9] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[10] K. Torigoe,et al. Purification and Characterization of the Human Interleukin-18 Receptor* , 1997, The Journal of Biological Chemistry.
[11] S. Dower,et al. Identification of Threonine 66 as a Functionally Critical Residue of the Interleukin-1 Receptor-associated Kinase* , 2002, The Journal of Biological Chemistry.
[12] C. Coban,et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction , 2005, The Journal of experimental medicine.
[13] G. Sen,et al. A critical role for IRAK4 kinase activity in Toll-like receptor–mediated innate immunity , 2007, The Journal of experimental medicine.
[14] P. Preshaw,et al. The expanding family of interleukin‐1 cytokines and their role in destructive inflammatory disorders , 2007, Clinical and experimental immunology.
[15] M. Labow,et al. The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor. , 2000, Clinical immunology.
[16] Sophie Janssens,et al. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. , 2003, Molecular cell.
[17] J. Ninomiya-Tsuji,et al. IRAK-mediated Translocation of TRAF6 and TAB2 in the Interleukin-1-induced Activation of NFκB* , 2001, The Journal of Biological Chemistry.
[18] L. Ziegler‐Heitbrock,et al. Tolerance Induced by the Lipopeptide Pam3Cys Is Due to Ablation of IL-1R-Associated Kinase-11 , 2004, The Journal of Immunology.
[19] K. Irie,et al. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. , 2000, Molecular cell.
[20] S. Akira,et al. IL-18 Directs Autoreactive T Cells and Promotes Autodestruction in the Central Nervous System Via Induction of IFN-γ by NK Cells1 , 2000, The Journal of Immunology.
[21] S. Morony,et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. , 1999, Genes & development.
[22] S. Mizel,et al. Gram-negative Flagellin-induced Self-tolerance Is Associated with a Block in Interleukin-1 Receptor-associated Kinase Release from Toll-like Receptor 5* , 2002, The Journal of Biological Chemistry.
[23] Douglas K. Miller,et al. The Interleukin-1 Receptor-associated Kinase Is Degraded by Proteasomes following Its Phosphorylation* , 1997, The Journal of Biological Chemistry.
[24] Jae-Geun Yoon,et al. CpG DNA Induces Self and Cross-Hyporesponsiveness of RAW264.7 Cells in Response to CpG DNA and Lipopolysaccharide: Alterations in IL-1 Receptor-Associated Kinase Expression1 , 2003, The Journal of Immunology.
[25] Zhaodan Cao,et al. TRAF6 is a signal transducer for interleukin-1 , 1996, Nature.
[26] Z. Cao,et al. IRAK: A Kinase Associated with the Interleukin-1 Receptor , 1996, Science.
[27] F. Martinon,et al. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor , 2000, Nature Cell Biology.
[28] M. Sweet,et al. T1/ST2--an IL-1 receptor-like modulator of immune responses. , 2004, Cytokine & growth factor reviews.
[29] C. McCall,et al. Endotoxin-adapted septic shock leukocytes selectively alter production of sIL-1RA and IL-1beta. , 2001, Shock.
[30] P. Feng,et al. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. , 1997, Science.
[31] A. Whitehead,et al. IRAK1b, a Novel Alternative Splice Variant of Interleukin-1 Receptor-associated Kinase (IRAK), Mediates Interleukin-1 Signaling and Has Prolonged Stability* , 2001, The Journal of Biological Chemistry.
[32] Crafford A. Harris,et al. Defective Interleukin (IL)-18–mediated Natural Killer and T Helper Cell Type 1 Responses in IL-1 Receptor–associated Kinase (IRAK)-deficient Mice , 1999, The Journal of experimental medicine.
[33] Zhijian J. Chen,et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK , 2001, Nature.
[34] T. Born,et al. Cloning of a Novel Receptor Subunit, AcPL, Required for Interleukin-18 Signaling* , 1998, The Journal of Biological Chemistry.
[35] Q. Gu,et al. Differential regulation of interleukin-1 receptor associated kinase 1 (IRAK1) splice variants. , 2007, Molecular immunology.
[36] G. Stark,et al. IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family* , 1999, The Journal of Biological Chemistry.
[37] K. Burns,et al. Inhibition of Interleukin 1 Receptor/Toll-like Receptor Signaling through the Alternatively Spliced, Short Form of MyD88 Is Due to Its Failure to Recruit IRAK-4 , 2003, The Journal of experimental medicine.
[38] J. Kirby,et al. Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy. , 2006, Current medicinal chemistry.
[39] J. Casanova,et al. IRAK4 Kinase Activity Is Redundant for Interleukin-1 (IL-1) Receptor-associated Kinase Phosphorylation and IL-1 Responsiveness* , 2004, Journal of Biological Chemistry.
[40] G. Stark,et al. Mutant Cells That Do Not Respond to Interleukin-1 (IL-1) Reveal a Novel Role for IL-1 Receptor-Associated Kinase , 1999, Molecular and Cellular Biology.
[41] W. Fung-Leung,et al. A Novel Splice Variant of Interleukin-1 Receptor (IL-1R)-Associated Kinase 1 Plays a Negative Regulatory Role in Toll/IL-1R-Induced Inflammatory Signaling , 2005, Molecular and Cellular Biology.
[42] Thomas Hartung,et al. Lipopolysaccharide- and Lipoteichoic Acid-Induced Tolerance and Cross-Tolerance: Distinct Alterations in IL-1 Receptor-Associated Kinase1 , 2002, The Journal of Immunology.
[43] J. Knop,et al. Effects of IL‐1 receptor‐associated kinase (IRAK) expression on IL‐1 signaling are independent of its kinase activity , 1999, FEBS letters.
[44] K. Burns,et al. Tollip Regulates Proinflammatory Responses to Interleukin-1 and Lipopolysaccharide , 2006, Molecular and Cellular Biology.
[45] A. Kuglstatter,et al. Cutting Edge: IL-1 Receptor-Associated Kinase 4 Structures Reveal Novel Features and Multiple Conformations , 2007, The Journal of Immunology.
[46] R. Brigelius-Flohé,et al. Cellular trafficking of the IL-1RI-associated kinase-1 requires intact kinase activity. , 2005, Biochemical and biophysical research communications.
[47] Z. Cao,et al. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. , 1997, Immunity.
[48] Liwu Li,et al. Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity , 2006, Immunologic research.
[49] C. Radu,et al. IL-1 Receptor-Associated Kinase 1 Regulates Susceptibility to Organ-Specific Autoimmunity1 , 2003, The Journal of Immunology.
[50] Xiaoxia Li,et al. Modulation of Toll–interleukin 1 receptor mediated signaling , 2005, Journal of Molecular Medicine.
[51] Zhengfan Jiang,et al. Interleukin-1 (IL-1) Receptor-Associated Kinase-Dependent IL-1-Induced Signaling Complexes Phosphorylate TAK1 and TAB2 at the Plasma Membrane and Activate TAK1 in the Cytosol , 2002, Molecular and Cellular Biology.
[52] Zhengfan Jiang,et al. Pellino 1 Is Required for Interleukin-1 (IL-1)-mediated Signaling through Its Interaction with the IL-1 Receptor-associated Kinase 4 (IRAK4)-IRAK-Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Complex* , 2003, The Journal of Biological Chemistry.
[53] M. Hayakawa,et al. A novel splice variant of mouse interleukin-1-receptor-associated kinase-1 (IRAK-1) activates nuclear factor-kappaB (NF-kappaB) and c-Jun N-terminal kinase (JNK). , 2003, The Biochemical journal.
[54] Zhijian J. Chen,et al. Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.
[55] Yingsu Huang,et al. Novel role and regulation of the interleukin-1 receptor associated kinase (IRAK) family proteins. , 2005, Cellular & molecular immunology.
[56] J. Cavaillon,et al. Gamma Interferon and Granulocyte/Monocyte Colony-stimulating Factor Prevent Endotoxin Tolerance in Human Monocytes by Promoting Interleukin-1 Receptor-associated Kinase Expression and Its Association to MyD88 and Not by Modulating TLR4 Expression* , 2002, The Journal of Biological Chemistry.
[57] M. J. Cody,et al. Induction of In Vitro Reprogramming by Toll-Like Receptor (TLR)2 and TLR4 Agonists in Murine Macrophages: Effects of TLR “Homotolerance” Versus “Heterotolerance” on NF-κB Signaling Pathway Components1 , 2003, The Journal of Immunology.
[58] S. Janssens,et al. Pellino proteins are more than scaffold proteins in TLR/IL‐1R signalling: A role as novel RING E3–ubiquitin‐ligases , 2006, FEBS letters.
[59] M. Hardy,et al. The Murine Irak2 Gene Encodes Four Alternatively Spliced Isoforms, Two of Which Are Inhibitory* , 2004, Journal of Biological Chemistry.
[60] H. Gram,et al. IRAK-4 Kinase Activity Is Required for Interleukin-1 (IL-1) Receptor- and Toll-like Receptor 7-mediated Signaling and Gene Expression* , 2007, Journal of Biological Chemistry.
[61] Sankar Ghosh,et al. Negative Regulation of Toll-like Receptor-mediated Signaling by Tollip* , 2002, The Journal of Biological Chemistry.
[62] A. Sher,et al. Cooperation of Toll-like receptor signals in innate immune defence , 2007, Nature Reviews Immunology.
[63] C. Janeway,et al. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. , 1999, Genes & development.
[64] R. Brigelius-Flohé,et al. Translocation of the interleukin‐1 receptor‐associated kinase‐1 (IRAK‐1) into the nucleus , 2000, FEBS letters.
[65] S. Akira,et al. Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor–mediated immune responses but not in TCR signaling , 2007, The Journal of experimental medicine.
[66] Liwu Li,et al. Characterization of Interleukin-1 Receptor-associated Kinase in Normal and Endotoxin-tolerant Cells* , 2000, The Journal of Biological Chemistry.
[67] J. Swantek,et al. IL-1 Receptor-Associated Kinase Modulates Host Responsiveness to Endotoxin1 , 2000, The Journal of Immunology.